Stallergenes Inh. buy melinda
Start price
27.08.10
/
50%
€57.29
Target price
28.02.11
€63.00
Performance (%)
2.79%
End price
28.02.11
€58.89
Summary
This prediction ended on 28.02.11 with a price of €58.89. With a performance of 2.79%, the BUY prediction by melinda for Stallergenes Inh. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Stallergenes Inh. | - | - | - | - |
| iShares Core DAX® | -0.436% | 1.181% | 14.210% | 57.331% |
| iShares Nasdaq 100 | 0.854% | 1.475% | 5.797% | 88.129% |
| iShares Nikkei 225® | 2.652% | 6.401% | 19.133% | 49.690% |
| iShares S&P 500 | 1.190% | 1.169% | 2.686% | 59.994% |
Comments by melinda for this prediction
In the thread Stallergenes Inh. diskutieren
Biopharma-
Stallergenes ist ein biopharmazeutisches Labor in Europa, spezialisiert auf die Behandlung von Atemwegserkrankungen, Asthma Nashorn
(Laufzeit überschritten)
